{"id":63939,"date":"2025-02-07T14:07:03","date_gmt":"2025-02-07T17:07:03","guid":{"rendered":"https:\/\/insurancecorp.com.br\/pt\/?p=63939"},"modified":"2025-02-07T14:07:03","modified_gmt":"2025-02-07T17:07:03","slug":"ans-recebe-contribuicoes-para-atualizacao-do-rol-2","status":"publish","type":"post","link":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/","title":{"rendered":"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol"},"content":{"rendered":"<p>A\u00a0Ag\u00eancia Nacional de Sa\u00fade Suplementar(ANS) abriu, na quinta-feira, 6\/2, a\u00a0<a href=\"https:\/\/componentes-portal.ans.gov.br\/link\/ConsultaPublica\/150\" target=\"_blank\" rel=\"noopener noreferrer\">Consulta P\u00fablica 150<\/a>, com o objetivo de obter contribui\u00e7\u00f5es sobre a proposta de atualiza\u00e7\u00e3o do Rol de Procedimentos e Eventos em Sa\u00fade para as seguintes tecnologias:<\/p>\n<p><span class=\"v1xnormaltextrun\">&#8211; Selpercatinibe, medicamento a ser usado como primeira op\u00e7\u00e3o para tratamento do c\u00e2ncer de pulm\u00e3o avan\u00e7ado com muta\u00e7\u00e3o denominada RET positivo; e<\/span><span class=\"v1xeop\">\u00a0<\/span><\/p>\n<p><span class=\"v1xnormaltextrun\">&#8211; Ivosidenibe, para o tratamento de c\u00e2ncer avan\u00e7ado das vias biliares em que houve progress\u00e3o da doen\u00e7a mesmo com o uso da primeira op\u00e7\u00e3o de tratamento sist\u00eamico em pacientes com muta\u00e7\u00e3o R132 do gene IDH1.<\/span><span class=\"v1xeop\">\u00a0<\/span><\/p>\n<p><span class=\"v1xnormaltextrun\">Por terem recomenda\u00e7\u00e3o preliminar desfavor\u00e1vel \u00e0 incorpora\u00e7\u00e3o ao Rol pela \u00e1rea t\u00e9cnica da ANS, as duas propostas tamb\u00e9m passar\u00e3o por audi\u00eancia p\u00fablica, que ser\u00e1 realizada no dia 25\/2, cujas informa\u00e7\u00f5es ser\u00e3o divulgadas em breve.<\/span><span class=\"v1xeop\">\u00a0<\/span><\/p>\n<p><span class=\"v1xnormaltextrun\">As tecnologias foram aprovadas para irem \u00e0 consulta p\u00fablica durante a 2\u00aa Reuni\u00e3o Extraordin\u00e1ria da Diretoria Colegiada (DICOL) de 2025, realizada no dia 3\/2. Para assistir \u00e0 reuni\u00e3o na \u00edntegra,\u00a0<\/span><a href=\"https:\/\/www.youtube.com\/watch?v=n3v_vxMrkW0\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"v1xnormaltextrun\">clique aqui<\/span><\/a><span class=\"v1xnormaltextrun\">.\u00a0<\/span><span class=\"v1xeop\">\u00a0<\/span><\/p>\n<p><span class=\"v1xnormaltextrun\">Os interessados podem enviar suas contribui\u00e7\u00f5es at\u00e9 25\/2 no pr\u00f3prio site da ANS, onde tamb\u00e9m est\u00e3o dispon\u00edveis os documentos relacionados \u00e0s propostas durante o per\u00edodo de?consulta. Para se informar e participar,\u00a0<a href=\"https:\/\/componentes-portal.ans.gov.br\/link\/ConsultaPublica\/150\" target=\"_blank\" rel=\"noopener noreferrer\">clique aqui<\/a>.<\/span><span class=\"v1xeop\">\u00a0<\/span><\/p>\n<p><span class=\"v1xnormaltextrun\">Vale lembrar que os formul\u00e1rios para envio de contribui\u00e7\u00f5es das?consultas p\u00fablicas para a atualiza\u00e7\u00e3o do Rol foram reformulados. Com a altera\u00e7\u00e3o, a sociedade poder\u00e1 informar se?concorda;?discorda;?ou?concorda\/discorda?parcialmente das incorpora\u00e7\u00f5es.? Antes da mudan\u00e7a, as classifica\u00e7\u00f5es dos tipos de opini\u00e3o dispon\u00edveis eram: concordo; discordo; ou concordo\/discordo parcialmente da recomenda\u00e7\u00e3o preliminar da ANS. O objetivo da modifica\u00e7\u00e3o \u00e9 conferir maior clareza e transpar\u00eancia ao processo de participa\u00e7\u00e3o social.<\/span><\/p>\n<p><strong>Assessoria de imprensa da ANS<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A\u00a0Ag\u00eancia Nacional de Sa\u00fade Suplementar(ANS) abriu, na quinta-feira, 6\/2, a\u00a0Consulta P\u00fablica 150, com o objetivo de obter contribui\u00e7\u00f5es sobre a proposta de atualiza\u00e7\u00e3o do Rol de Procedimentos e Eventos em Sa\u00fade para as seguintes tecnologias: &#8211; Selpercatinibe, medicamento a ser usado como primeira op\u00e7\u00e3o para tratamento do c\u00e2ncer de pulm\u00e3o avan\u00e7ado com muta\u00e7\u00e3o denominada RET [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[380],"tags":[779,887,3054,6360,8700],"class_list":["post-63939","post","type-post","status-publish","format-standard","hentry","category-ans","tag-ans","tag-atualizacao","tag-contribuicoes","tag-recebe","tag-rol"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol | Revista Insurance Corp | PT-BR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol | Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"og:description\" content=\"A\u00a0Ag\u00eancia Nacional de Sa\u00fade Suplementar(ANS) abriu, na quinta-feira, 6\/2, a\u00a0Consulta P\u00fablica 150, com o objetivo de obter contribui\u00e7\u00f5es sobre a proposta de atualiza\u00e7\u00e3o do Rol de Procedimentos e Eventos em Sa\u00fade para as seguintes tecnologias: &#8211; Selpercatinibe, medicamento a ser usado como primeira op\u00e7\u00e3o para tratamento do c\u00e2ncer de pulm\u00e3o avan\u00e7ado com muta\u00e7\u00e3o denominada RET [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-07T17:07:03+00:00\" \/>\n<meta name=\"author\" content=\"Publica\u00e7\u00e3o\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Publica\u00e7\u00e3o\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2025\\\/02\\\/07\\\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2025\\\/02\\\/07\\\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\\\/\"},\"author\":{\"name\":\"Publica\u00e7\u00e3o\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/person\\\/1b69c8cf325f0b7167f1b171f52df4af\"},\"headline\":\"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol\",\"datePublished\":\"2025-02-07T17:07:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2025\\\/02\\\/07\\\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\\\/\"},\"wordCount\":322,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#organization\"},\"keywords\":[\"ans\",\"atualiza\u00e7\u00e3o\",\"contribui\u00e7\u00f5es\",\"recebe\",\"ROL\"],\"articleSection\":[\"ANS\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2025\\\/02\\\/07\\\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2025\\\/02\\\/07\\\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\\\/\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2025\\\/02\\\/07\\\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\\\/\",\"name\":\"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol | Revista Insurance Corp | PT-BR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#website\"},\"datePublished\":\"2025-02-07T17:07:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2025\\\/02\\\/07\\\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2025\\\/02\\\/07\\\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2025\\\/02\\\/07\\\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#website\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/\",\"name\":\"Revista Insurance Corp | PT-BR\",\"description\":\"A \u00fanica revista bil\u00edngue voltada ao mercado de seguro.\",\"publisher\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#organization\",\"name\":\"Revista Insurance Corp\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Revista Insurance Corp\"},\"image\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RevistaInsuranceCorp\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/person\\\/1b69c8cf325f0b7167f1b171f52df4af\",\"name\":\"Publica\u00e7\u00e3o\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g\",\"caption\":\"Publica\u00e7\u00e3o\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol | Revista Insurance Corp | PT-BR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/","og_locale":"pt_BR","og_type":"article","og_title":"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol | Revista Insurance Corp | PT-BR","og_description":"A\u00a0Ag\u00eancia Nacional de Sa\u00fade Suplementar(ANS) abriu, na quinta-feira, 6\/2, a\u00a0Consulta P\u00fablica 150, com o objetivo de obter contribui\u00e7\u00f5es sobre a proposta de atualiza\u00e7\u00e3o do Rol de Procedimentos e Eventos em Sa\u00fade para as seguintes tecnologias: &#8211; Selpercatinibe, medicamento a ser usado como primeira op\u00e7\u00e3o para tratamento do c\u00e2ncer de pulm\u00e3o avan\u00e7ado com muta\u00e7\u00e3o denominada RET [&hellip;]","og_url":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/","og_site_name":"Revista Insurance Corp | PT-BR","article_publisher":"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/","article_published_time":"2025-02-07T17:07:03+00:00","author":"Publica\u00e7\u00e3o","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Publica\u00e7\u00e3o","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/#article","isPartOf":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/"},"author":{"name":"Publica\u00e7\u00e3o","@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af"},"headline":"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol","datePublished":"2025-02-07T17:07:03+00:00","mainEntityOfPage":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/"},"wordCount":322,"commentCount":0,"publisher":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#organization"},"keywords":["ans","atualiza\u00e7\u00e3o","contribui\u00e7\u00f5es","recebe","ROL"],"articleSection":["ANS"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/","url":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/","name":"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol | Revista Insurance Corp | PT-BR","isPartOf":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#website"},"datePublished":"2025-02-07T17:07:03+00:00","breadcrumb":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/insurancecorp.com.br\/pt\/2025\/02\/07\/ans-recebe-contribuicoes-para-atualizacao-do-rol-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/insurancecorp.com.br\/pt\/"},{"@type":"ListItem","position":2,"name":"ANS recebe contribui\u00e7\u00f5es para atualiza\u00e7\u00e3o do Rol"}]},{"@type":"WebSite","@id":"https:\/\/insurancecorp.com.br\/pt\/#website","url":"https:\/\/insurancecorp.com.br\/pt\/","name":"Revista Insurance Corp | PT-BR","description":"A \u00fanica revista bil\u00edngue voltada ao mercado de seguro.","publisher":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/insurancecorp.com.br\/pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/insurancecorp.com.br\/pt\/#organization","name":"Revista Insurance Corp","url":"https:\/\/insurancecorp.com.br\/pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Revista Insurance Corp"},"image":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RevistaInsuranceCorp\/"]},{"@type":"Person","@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af","name":"Publica\u00e7\u00e3o","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g","caption":"Publica\u00e7\u00e3o"}}]}},"_links":{"self":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/63939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/comments?post=63939"}],"version-history":[{"count":1,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/63939\/revisions"}],"predecessor-version":[{"id":63940,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/63939\/revisions\/63940"}],"wp:attachment":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/media?parent=63939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/categories?post=63939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/tags?post=63939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}